201 related articles for article (PubMed ID: 10376932)
1. High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor.
Tsantili P; Tzartos SJ; Mamalaki A
J Neuroimmunol; 1999 Feb; 94(1-2):15-27. PubMed ID: 10376932
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
[TBL] [Abstract][Full Text] [Related]
3. Bacterial expression of a single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies.
Mamalaki A; Trakas N; Tzartos SJ
Eur J Immunol; 1993 Aug; 23(8):1839-45. PubMed ID: 8344344
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor.
Cardona A; Pritsch O; Dumas G; Bach JF; Dighiero G
Mol Immunol; 1995 Nov; 32(16):1215-23. PubMed ID: 8559146
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
[TBL] [Abstract][Full Text] [Related]
9. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
[TBL] [Abstract][Full Text] [Related]
10. Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.
Cochet O; Kenigsberg M; Delumeau I; Duchesne M; Schweighoffer F; Tocqué B; Teillaud JL
Mol Immunol; 1998 Dec; 35(17):1097-110. PubMed ID: 10395199
[TBL] [Abstract][Full Text] [Related]
11. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
12. Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin.
Song Z; Cai Y; Song D; Xu J; Yuan H; Wang L; Zhu X; Lin H; Breitling F; Dübel S
Hybridoma; 1997 Jun; 16(3):235-41. PubMed ID: 9219033
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the octapeptide angiotensin II with a high-affinity single-chain Fv and with peptides derived from the antibody paratope.
Cohen P; Laune D; Teulon I; Combes T; Pugnière M; Badouaille G; Granier C; Mani JC; Simon D
J Immunol Methods; 2001 Aug; 254(1-2):147-60. PubMed ID: 11406160
[TBL] [Abstract][Full Text] [Related]
14. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies.
Fostieri E; Tzartos SJ; Berrih-Aknin S; Beeson D; Mamalaki A
Eur J Immunol; 2005 Feb; 35(2):632-43. PubMed ID: 15627975
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
16. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
Sophianos D; Tzartos SJ
J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
[TBL] [Abstract][Full Text] [Related]
18. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
19. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity.
Trakas N; Tzartos SJ
J Neuroimmunol; 2001 Nov; 120(1-2):42-9. PubMed ID: 11694318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
